Alphamab Oncology (FRA:3NK)
0.8350
-0.0100 (-1.18%)
At close: Sep 18, 2026
| Market Cap | 834.23M -31.5% |
| Revenue (ttm) | 66.75M -34.1% |
| Net Income | -22.68M |
| EPS | -0.02 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 0.8350 |
| Previous Close | 0.8450 |
| Day's Range | 0.8350 - 0.8350 |
| 52-Week Range | 0.6950 - 1.6800 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 27, 2026 |